APPLICATION
ANDA077820
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-11
LATEST ACTION
2017-03-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
GLIPIZIDEDiscontinued
GLIPIZIDE 10MG · TABLET · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 5MG · TABLET · ORAL
Approval history
2017-03-31Labeling · Supplement 12 · standardAP
2015-08-17Labeling · Supplement 8 · standardAP
2015-08-17Labeling · Supplement 9 · standardAP
2015-06-17Manufacturing (CMC) · Supplement 11 · unknownAP
2009-03-23Labeling · Supplement 2AP
2006-07-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.